Skip to content
Advertisement

FILE - In this April 14, 2020 file photo, a woman holds her hand out to have blood collected for COVID-19 antibodies at a drive-thru site in Hempstead, N.Y. U.S. regulators on Monday, May 4 pulled back a decision that allowed scores of coronavirus blood tests to hit the market without first providing proof that they worked. The Food and Drug Administration said it took the action because some sellers have made false claims about the tests and their accuracy. (AP Photo/Seth Wenig, File)

FILE - In this April 14, 2020 file photo, a woman holds her hand out to have blood collected for COVID-19 antibodies at a drive-thru site in Hempstead, N.Y. U.S. regulators on Monday, May 4 pulled back a decision that allowed scores of coronavirus blood tests to hit the market without first providing proof that they worked. The Food and Drug Administration said it took the action because some sellers have made false claims about the tests and their accuracy. (AP Photo/Seth Wenig, File)

Featured Photo Galleries